scholarly journals Analysis of Streptococcus pyogenes reinfection in pediatric patients in Japan

2021 ◽  
Vol 6 (3) ◽  
pp. 076-082
Author(s):  
Masaaki Minami ◽  
Ryoko Sakakibara ◽  
Mika Watanabe ◽  
Hideo Morita

Acute pharyngitis and tonsillitis caused by Streptococcus pyogenes are common pediatric infectious diseases. Although the presence of penicillin-resistant S. pyogenes has not been confirmed in Japan, the re-isolation rate of S. pyogenes after antimicrobial treatment has been increasing. Thus, we attempted to determine whether the presence of S. pyogenes in pediatric patients treated with antimicrobial treatment was because of treatment failure or reinfection. We examined 19 patients who visited Daido Hospital between 2013 and 2017. The patient age, drug susceptibility patterns of the isolated bacteria, and random amplified polymorphic DNA (RAPD) analysis results were evaluated. The patient age ranged from 3 months to 9 years, seven patients were 5 years old. Seven patients showed consistent drug susceptible test results, and 12 patients showed inconsistent drug susceptible test results. Among these 12 patients, nine patients showed a greater decrease in drug susceptibility than the other three patients. Genetic mismatch was confirmed by RAPD analysis in all seven patients with consistent drug susceptible results. The paired S. pyogenes isolates from the same patient showed the presence of different bacteria. Our results indicate that, in many cases, re-isolation of S. pyogenes is not due to treatment failure, but due to reinfection with other clinical isolates.

Author(s):  
Cenikli U ◽  
◽  
Bir LS ◽  
Degirmenci E ◽  
Ardıç FN ◽  
...  

Background: Essential Tremor (ET) is the most common movement disorder, yet the location of the primary disease substrate continues to be a matter of debate. In this study, we aimed to evaluate ocular movement abnormalities with Electrooculography (EOG) in patients with ET to find a possible location of disease pathology. Methods: Electrooculographic evaluation including saccade, tracking, optokinetic, gaze and positional tests were performed to 36 ET patients and 36 healthy subjects. Patient age on the onset of the tremor, duration of the disease, characteristics and the location of the tremor were also investigated. Fahn- Tolosa-Marin tremor rating scale was used to determine the tremor severity. Differences of abnormal test results between patient and control groups were analysed with Pearson’s and Fisher’s Exact and correlation analyses of EOG tests and clinical data were performed with Spearman’s and Pearson’s correlation tests. Results: There was not any significant difference in EOG tests between the ET patients and controls. Significant correlation was only found between EOG abnormality and patient age in correlation analyses. Conclusions: Our results showed that ET patients may not have specific EOG test abnormalities. These tests would be used especially in the different diagnosis of other movement disorders.


2020 ◽  
Vol 145 (2) ◽  
pp. AB41
Author(s):  
Jocelyn Jia ◽  
Edmond Chan ◽  
Vishal Avinashi ◽  
Elaine Hsu ◽  
Hin Hin Ko ◽  
...  

Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 1685-1685 ◽  
Author(s):  
Elliott P. Vichinsky ◽  
Lynne Neumayr ◽  
Ann Earles ◽  
Christine Aguilar ◽  
Shanda Robertson ◽  
...  

Abstract Avascular necrosis (AVN) of the hips affects half of sickle cell anemia (SCA) patients and can rapidly lead to total collapse of the hip. Treatment with supportive therapy alone is unsuccessful and results in half of all patients requiring hip surgery within 2 years of diagnosis. Prognosis in advanced cases is dismal, with surgery eventually required in all patients. Alternative therapies including aggressive physical therapy (PT) and hip coring decompression (HCD) may improve the natural history of AVN but neither have been evaluated prospectively in SCD. The goal of the prospective randomized National AVN Trial in SCA is to evaluate the safety of HCD and PT for AVN. 46 patients were randomized to have either HCD of their study hip followed by 6 weeks of an aggressive PT protocol, or to undergo only the PT protocol. Both treatment arms are balanced for Ficat stage and patient age. Outcome measures include clinical improvement as measured by the Children’s Hospital Oakland Hip Evaluation Scale (CHOHES), a 100 point validated scale that assesses hip function and pain associated with AVN in SCA. Additional measures include X-ray progression and the need for surgical intervention. This report presents hip survival rates in 39 study patients: 17 patients underwent HCD and 22 were treated in the PT arm. Average patient age was 26 (range 10 to 50). 67% had bilateral disease. The average follow-up is currently 40 months. In the survival graph, treatment failure was defined as additional hip surgery. 4 of the 39 study hips (10%) were treatment failures: 1/9 (11%) of Stage I, 3/19 (16%) of Stage II, and 0/11 (0%) of Stage III hips. Figure Figure In addition to a low treatment failure rate, hips in each Ficat stage show evidence of clinical improvement. CHOHES scores improved 17 points at 1 year and 22 points at 2 years; even Stage III shows a 20 point improvement at 1 year and 21 points at 2 years. Our data indicates that both HCD and aggressive PT are beneficial in the treatment of AVN in SCA. PT may be effective in the treatment of even fairly advanced Stage III AVN. The AVN Trial in SCA is ongoing; patients will be followed for 3 to 5 years, and a comparison of HCD to aggressive PT will be made upon completion.


2020 ◽  
Vol 17 (4) ◽  
pp. 779-783
Author(s):  
V. V. Potyomkin ◽  
E. V. Goltsman

Phenylephrine test is one of the main factors determining the possibility of performing superior tarsal muscle resection. However, the influence of various factors on its result remains unexplored.Aim. To evaluate the effect of patient age, degree of ptosis, and levator muscle function on the result of the phenylephrine test.Patients and methods. 45 patients were examined (64 eyelids). The following examinations were performed for all patients: assessment of the degree of ptosis, levator muscle function and the phenylephrine test.Results. Age and the degree of ptosis do not affect the results of the phenylephrine test. Reduced levator muscle function leads to a decrease of the phenylephrine test results.Conclusion. The phenylephrine test remains an important criteria for patient selection for the planning superior tarsal muscle resection. Levator muscle function does affect the phenylephrine test result. 


Blood ◽  
2017 ◽  
Vol 130 (Suppl_1) ◽  
pp. 851-851
Author(s):  
Tara M. Robinson ◽  
Ephraim J. Fuchs ◽  
Mei-Jie Zhang ◽  
Myriam Labopin ◽  
Andrew St. Martin ◽  
...  

Abstract An HLA-matched sibling has been considered the optimal donor for allogeneic hematopoietic cell transplantation (HSCT). However, several potential transplant recipients may have a haploidentical sibling or an offspring who may also serve as donors. In this study, we sought to determine the optimal alternative related donor (haploidentical sibling or an offspring) as compared to an HLA-matched sibling. The primary objective was comparison of chronic graft-versus-host disease (GVHD). Secondary outcomes included acute GVHD, non-relapse mortality (NRM), relapse, treatment failure (relapse or death, inverse of relapse-free survival) and overall mortality. The study population included 4540 donor-recipient pairs (n=218 haploidentical sibling; n=218 offspring; n=4104 HLA-matched sibling) with acute myeloid (n=3617) and acute lymphoblastic (n=923) leukemia transplanted in 2008 to 2015. There were few offspring (n=87) who donated to patients aged 18-54 years and haploidentical siblings (n=61) who donated to patients aged 55-76 years and were excluded from the analysis. Post-transplant cyclophosphamide (PT-Cy) with calcineurin inhibitor (CNI) and mycophenolate was used for GVHD prophylaxis for all haploidentical HSCTs. HLA-matched siblings received CNI-containing GVHD prophylaxis; CNI with methotrexate was the predominant prophylaxis regimen. Patient age was correlated with donor age and donor-recipient relationship. Bone marrow was the predominant graft for haploidentical HSCTs (64%) and peripheral blood (89%) for HLA-matched sibling HSCTs. Younger patients (age 18-54 years) of were more likely to receive reduced intensity conditioning regimens for haploidentical HSCTs compared to HLA-matched sibling HSCTs (22%). Among older patients, conditioning regimen intensity did not differ by donor type. Exploratory analysis confirmed differences in survival by patient age. Therefore, based on differences in survival by patient age, two age groups were created: 18 - 54 years and 55 - 76 years and within each patient age group, donor-recipient relationship and its effect on transplant outcomes were tested using Cox regression models. In addition to the standard Cox regression model, we also performed a matched-pair analysis. Recipients of haploidentical HSCT (cases; n=436) were matched to HLA-matched siblings (controls; n=1707) on age, disease and disease risk index. 88% of patients aged 18-54 years were matched to 4 controls and 96% of patients aged 55-76 years were matched to 4 controls. The median difference in age between cases and controls were 0.08 (range 0-9.9) years for patients aged 18-54 years and 0.05 (0 - 9.5) years for patients aged 55-76 years. The results of multivariate Cox regression and matched-pair analysis are shown in Tables 1, 2. Among patients aged 18-54 years, chronic GVHD risks were lower after haploidentical sibling compared to HLA-matched sibling HSCT. There were no differences in acute GVHD, NRM, relapse, treatment failure or overall mortality. Among patients aged 55-76 years, acute and chronic GVHD risks were lower after offspring compared to HLA-matched sibling HSCT. But risks for NRM, treatment failure and overall mortality were higher after offspring compared to HLA-matched sibling HSCT. The 2-year probabilities of overall survival, adjusted for disease risk index and sex are shown in Figure 1. In summary, chronic GVHD rates were lower after haploidentical HSCT with PT-Cy containing GVHD prophylaxis regimens compared to HLA-matched sibling HSCT for all patients. Whether this can be attributed solely to the GVHD prophylaxis regimen or in part attributed to use of peripheral blood grafts for HLA-matched sibling HSCT must be studied further in a setting in which PT-Cy containing GVHD prophylaxis is used for HLA-matched sibling HSCT. Despite lower chronic GVHD with haploidentical sibling donor HSCT with PT-Cy, NRM and overall survival did not differ by donor type for patients aged 18-54 years. However, for patients aged 55 - 76 years, despite lower chronic GVHD with offspring donor HSCT with PT-Cy, NRM was higher and overall survival was lower compared to HLA-matched sibling HSCT. Definitive proof of these findings would require a prospective randomized trial. Disclosures Ciceri: GSK: Other: B-thalassemia gene therapy was developed by Fondazione Telethon and Ospedale San Raffaele and has been inlicenced by GSK that provides funding for the clinical trial, Research Funding. Mohty: Sanofi: Honoraria, Speakers Bureau.


Blood ◽  
2021 ◽  
Vol 138 (Supplement 1) ◽  
pp. 4938-4938
Author(s):  
Paige Reilly ◽  
Alexis Rodriguez ◽  
Cristiana Hentea

Abstract BACKGROUND Sickle cell disease (SCD) affects ~100,000 people in the US and is associated with multi-system acute and chronic complications that shorten lifespan. While most pediatric patients in the US survive beyond age 18, the risk of death increases dramatically during late adolescence and young adulthood. This surge is due partly to insufficient access to comprehensive sickle cell and subspecialty care. As a result, patients with episodic SCD care have high rates of ED use and hospitalization, incurring substantial cost. Emergency physicians, hospitalists, and primary care physicians are frequently responsible for these highly complex patients and studies suggest that they lack necessary SCD knowledge and training. Question banks have emerged as the most widely used educational resource among medical students and residents studying for licensing exams. Medical trainees favor question banks over all other learning platforms, including lecture, to learn new material and for review. Question banks feature "highest-yield" topics and may be viewed as the most important clinical knowledge to carry into practice. Our study aims to examine SCD-related content in the most popular commercial question bank to determine how this important teaching platform serves to educate medical trainees about the complex pathophysiology and scope of SCD. METHODS We obtained access to three question banks used by trainees to prepare for the current USMLE Step 1, Step 2, and Step 3 exams. The keyword "sickle cell" was entered into a search feature. Inclusion criteria consisted of question vignettes that included a patient with SCD. Exclusion criteria comprised questions featuring patients with sickle cell trait or other hemoglobinopathy and non-SCD questions with SCD-related answer choices. Resulting questions were analyzed for disease-related topic and patient age. Questions were assigned to one of the following categories, selected due to high incidence of clinically significant complications per NHLBI guidelines: vasooclusive crisis (VOC)/pain, fever/infection, stroke, acute chest syndrome (ACS), spleen, renal, priapism, or hepatobiliary. Questions outside of these categories were designated "other." Patient age was categorized by group: birth to 5 years, 6-10 years, 11-15 years, 16-20 years, and 20 years or older. For clinical vignettes with multiple questions in series, questions were categorized individually while the patient was counted once (ex: 5-year-old with VOC in first question, develops ACS in second question: one "VOC/pain," one "ACS," and one patient 0-5 years). Test questions that were unrelated to the clinical vignette were categorized by the patient's clinical history (ex: 12-year-old frequently hospitalized for pain and observed sickle-shaped RBCs on peripheral smear most likely has what sequence in the beta-globin gene? Categorized as "VOC/pain" and patient 11-15 years). RESULTS There were 9041 questions total in the three banks. "Hematology & Oncology" questions comprised 5.3% (478/9041) of content and less than 1% were tagged "sickle cell" (0.55%, 50/9041). However, SCD rarely formed the question content (0.24%, 22/9041). A total of 20 patients with SCD were presented in questions. Pediatric patients were featured in almost every question (90.0%, 18/20) and the median patient age was 7.5 years. Two questions involved adult patients (M, F; age 23) and both presented to the ER with pain. Acute VOC pain, including dactylitis, was the most common complaint (36.4%, 8/22), followed by patients with fever or infection (27.3%, 6/22). Acute chest syndrome and splenic dysfunction (from fibrosis) were each tested once and acute stroke was tested twice (Table 1). There were no questions about renal failure, priapism, hepatobiliary complications, or splenic sequestration. CONCLUSIONS Our study found a significant proportion of questions focused on acute SCD pain in pediatric patients. Adult SCD patients were largely omitted from this question bank's content. Given that medical trainees favor question banks over all other learning platforms, this finding may suggest a limited scope of understanding of this disease. Figure 1 Figure 1. Disclosures No relevant conflicts of interest to declare.


2020 ◽  
Vol 54 (4) ◽  
pp. 407-418
Author(s):  
Pamela Villalon-Pooley ◽  
Camila Hernandez-Veliz ◽  
Maria Fernanda Pinto-Chavez ◽  
Pierre Bourdiol
Keyword(s):  

Parmi les fractures cranio-faciales, celles affectant le condyle mandibulaire font partie des fractures les plus souvent rencontrées chez le patient en âge pédiatrique. L’évolution sans traitement peut produire une ankylose temporo-mandibulaire entraînant troubles fonctionnels et asymétrie de la croissance cranio-faciale. Le traitement traditionnellement chirurgical est d’un pronostic généralement réservé. Dans cet article est présenté le cas d’un patient, âgé de quatre ans, atteint d’ankylose fibreuse de l’articulation temporo-mandibulaire gauche, suite probable d’une fracture du col du condyle non-diagnostiquée. La libération fonctionnelle de la fibro-ankylose articulaire a été l’objectif de la première étape thérapeutique. Celle-ci a été suivie, à l’âge de sept ans, d’une distraction articulaire obtenue au moyen de butées occlusales controlatérales disposées côté droit. Ceci a produit un ajustement de la croissance dento-alvéolaire assurant à la fois un rattrapage du déficit de croissance unilatéral de départ et une néoformation condylienne par remodelage de l’articulation temporo-mandibulaire gauche. Quatre années après la mise en route de la phase orthopédique initiale, la fonction articulaire restaurée et l’équilibre facial obtenu restent stables chez ce jeune patient


2012 ◽  
Vol 32 (S 01) ◽  
pp. S39-S42 ◽  
Author(s):  
S. Kocher ◽  
G. Asmelash ◽  
V. Makki ◽  
S. Müller ◽  
S. Krekeler ◽  
...  

SummaryThe retrospective observational study surveys the relationship between development of inhibitors in the treatment of haemophilia patients and risk factors such as changing FVIII products. A total of 119 patients were included in this study, 198 changes of FVIII products were evaluated. Results: During the observation period of 12 months none of the patients developed an inhibitor, which was temporally associated with a change of FVIII products. A frequent change of FVIII products didn’t lead to an increase in inhibitor risk. The change between plasmatic and recombinant preparations could not be confirmed as a risk factor. Furthermore, no correlation between treatment regimens, severity, patient age and comorbidities of the patients could be found.


Sign in / Sign up

Export Citation Format

Share Document